Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Rank in Stocks #29676
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Share Price
$0.20877985
Market Cap
$20.11M
Change (1 day)
-3.03%
Change (1 year)
-66.13%
Country
JP
Trade Modalis Therapeutics Corporation (4883)

Category

Stock split history for Modalis Therapeutics Corporation (4883)
Modalis Therapeutics Corporation stock (symbol: 4883) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 19, 2026.
One 4883 share bought prior to Aug 19, 2026 would equal to 0 4883 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR